Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $761.4M |
| Sales growthchange from the year before | +12.8% |
| Gross marginshare of sales left after the direct cost of what it sells | 98.3% |
| Operating marginshare of sales left after running the business | 5.9% |
| Net marginshare of sales kept as profit | 13.1% |
| Free-cash-flow marginspare cash generated per $100 of sales | 18.6% |
| Return on invested capitalprofit made on each $100 put into the business | 5.5% |
| Return on equityprofit vs. shareholders' accounting value | 15.4% |
| Change in share countnegative = the company is buying back its shares | +5.7% |
3 insiders sold $11.7M (98% under pre-arranged plans) on the open market.
| Lyon Joseph DouglasSee Remarks | SoldAug 3 | 1,540 shat $114.16 · $176K |
| Maduck SeanSee Remarks | Sold (plan)Aug 3 | 20,305 shat $114.70 · $2.3M |
| Mokari AtabakChief Financial Officer | Sold (plan)Jul 30 | 80,000 shat $114.71 · $9.2M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy